Silexion Therapeutics prices ~$5M public offering of shares and warrants at $1.35/unit

Silexion Therapeutics Corp

Gross proceeds expected ~$5M; net proceeds ~$4.26M after placement agent fees and expenses.
Offering includes 3,703,703 ordinary shares (or pre-funded warrants) and identical number of warrants exercisable at $1.35 for 5 years.
Closing expected January 17, 2025; placement agent H.C. Wainwright & Co. receives 7% cash fee plus 1% management fee.
Proceeds to advance pre-clinical studies for KRAS-driven cancer RNAi therapies and for general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.